| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
24,880,000 |
| Market
Cap: |
17.72(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.5165 - $5.75 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Eyenovia is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its microdose array print (MAP™) platform technology, branded the Optejet®. MicroPine is Co.'s topical therapy for the treatment of progressive myopia, a back-of-the-eye ocular disease associated with pathologic axial elongation and sclero-retinal stretching. MicroLine is Co.'s pharmacologic treatment for presbyopia, a non-preventable, age-related hardening of the lens that causes the gradual loss of the eye's ability to focus on near objects and impairs near visual acuity. Mydcombi™ is Co.'s fixed combination formulation of tropicamide-phenylephrine for mydriasis.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
160,717 |
165,607 |
357,711 |
654,329 |
| Total Buy Value |
$176,411 |
$183,061 |
$635,654 |
$1,182,496 |
| Total People Bought |
1 |
2 |
6 |
7 |
| Total Buy Transactions |
3 |
4 |
15 |
28 |
| Total Shares Sold |
0 |
0 |
94,000 |
234,000 |
| Total Sell Value |
$0 |
$0 |
$508,560 |
$1,148,560 |
| Total People Sold |
0 |
0 |
2 |
2 |
| Total Sell Transactions |
0 |
0 |
2 |
5 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Labelle Curt H |
Director |
– • – |
2020-09-11 |
4 |
A |
$0.00 |
$0 |
D/D |
7,288 |
35,273 |
|
- |
|
| Mario Ernest |
Director |
– • – |
2020-09-11 |
4 |
A |
$0.00 |
$0 |
D/D |
7,288 |
334,527 |
|
- |
|
| Grant Stuart M. |
|
– – • |
2020-08-20 |
4 |
B |
$2.06 |
$929,434 |
D/D |
451,620 |
4,044,748 |
0.01 |
70% |
|
| Grant Stuart M. |
|
– – • |
2020-08-19 |
4 |
B |
$3.60 |
$1,198,800 |
D/D |
333,000 |
3,593,128 |
0.01 |
62% |
|
54 Records found
|
|
Page 3 of 3 |
|
|
0.08 (13.37%) 
